CAP-LUSO: Capacity building to enhance US federal funding compliance and administration in Mozambique and strengthenening exchange ofknowledge betweeen PALOP research centers

项目摘要 Centro de Investigaçao em Saude de Manhiça（CISM）- Fundaçao Manhiça是一个领先的研究机构， 中心在非洲南部。成立于1996年，是莫桑比克的一个独立机构， 2006年，国际医学科学理事会促进和进行生物医学研究的优先卫生领域，如疟疾， 肺结核、艾滋病和呼吸道疾病。展示CISM的承诺，生物医学研究， 该机构作为RTS疟疾疫苗的III期临床试验中心。 二十年来，CISM已经证明了制定提案，筹集资金和建立 合作伙伴关系。2016年，CISM获得了美国国立卫生研究院（NIH）R 01资助， 第一次作为主要获奖者。对于这项研究，CISM领导了一个由三个国际合作者组成的联盟， 低收入和中等收入国家机构。此外，在去年，CISM收到了第二个R 01， 一个主要的获奖者，并建立了与贝勒医学院（医学院）作为R 01子获奖者的合作。 虽然CISM在实施上述NIH项目方面一直很有效，但行政支持 在日常业务和赠款管理方面突出了缺陷。这是一个挑战和学习， 为CISM赠款管理团队的机会。作为一名副获奖者，这是一个机会， 为CISM赠款管理管理人员进行培训，由CISM赠款管理人员， 必要的技能，以确保CISM是在完全符合美国联邦资助规则和条例。的 一个名为“CAP-LUSO”的项目，将为国际预防犯罪和刑事司法培训学员提供分享学到的最佳做法的机会 与国际安全理事会方案小组和其他葡语非洲国家-在一个“培训教练员”的格式。 经验丰富的赠款经理Carole Amroune将担任主要调查员，并领导CAP- LUSO项目。她有九年的工作经验，在国际安全理事会的母公司，ISGlobal，并将设在 Manhiça确保与CISM行政赠款管理保持一致的适当培训计划 需求她还将支持CISM项目股的重组。她管理曼联的经验 州联邦基金在国外的背景和机构将提供额外的知识共享 机会 两名接受培训的CISM高级行政人员将由中国国际贸易促进委员会组织内部培训 会议将知识转移到CISM项目单位，行政助理和校长 investigators.此外，扩大CAP-LUSO的影响，并分享11国集团赠款以外的最佳做法 资助的培训机会，CISM将组织一个美国联邦资助赠款管理 为葡语非洲国家机构举办的讲习班。所提供的培训将使 葡萄牙语非洲国家机构有信心在各自国家寻求NIH资助 影响受益人的健康。

PROJECT SUMMARY Centro de Investigaçao em Saude de Manhiça (CISM) – Fundaçao Manhiça is one of the leading research centers in southern Africa. Created in 1996 and established as an independent Mozambican institution in 2006, CISM promotes and conducts biomedical research in priority health areas such as malaria, tuberculosis, HIV, and respiratory disease. Demonstrating CISM's commitment to biomedical research, the institution served as a RTS Phase III Clinical Trial site for the malaria vaccine. For two decades, CISM has demonstrated the capacity to develop proposals, raise funding, and establish collaborative partnerships. In 2016, CISM obtained National Institutes of Health (NIH) R01 funding for the first time as prime awardee. For this study, CISM led a consortium of three international collaborators from low- and middle-income country institutions. Additional, within the last year, CISM received a second R01 as a prime awardee and built a collaboration with Baylor College of Medicine (BCM) as an R01 sub-awardee. While CISM has been effective in implementing the aforementioned NIH projects, administrative support flaws were highlighted in daily operations and grants management. This serves as a challenge and learning opportunity for the CISM grants management team. As a sub-awardee to BCM, this presents an opportunity for CISM grants management administrators to be trained by BCM grants management staff to reinforce the skills necessary to ensure CISM is in full compliance with US federal funding rules and regulations. The project, “CAP-LUSO”, will provide the opportunity for BCM CISM trainees to share learned best practices with CISM program teams and other Portuguese-speaking African countries – in a “train the trainer” format. Experienced grants manager, Carole Amroune, will serve as the principle investigator and lead the CAP- LUSO project. She has nine years' experience working at CISM parent entity, ISGlobal, and will be based in Manhiça to ensure an appropriate training plan that is aligned with CISM administrative grants management needs. She will also support reorganization of the CISM Projects Unit. Her experience managing United States federal funds in foreign contexts and institutions will provide additional knowledge sharing opportunities. The two CISM senior administrative staff to receive training from BCM will organize internal training sessions to transfer knowledge to the CISM Projects Unit, administrative assistants, and principal investigators. Further, to broaden the impact of CAP-LUSO and share best practices beyond the G11 grant funded training opportunity, CISM will organize a United States federal funding grants management workshop for Portuguese-speaking African country institutions. The training imparted will enable Portuguese-speaking African country institutions to confidently pursue NIH funding in their respective countries and impact the health of their beneficiaries.